Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print

Industry News

Related Searches:

Filter by:

December 21, 2012
Halozyme is eligible to receive milestones and royalties   Read More »
December 20, 2012
Adds formulation development capabilities   Read More »
December 20, 2012
IMF facility has PROVENGE manufacturing capabilities   Read More »
December 20, 2012
Aims to identify new targets through shared research   Read More »
December 19, 2012
Adds granulation roller compactor   Read More »
December 18, 2012
Seeks development and commercialization partner   Read More »
December 18, 2012
Will identify and commercialize alternative API technologies   Read More »
December 18, 2012
To market Umetrics chemometrics software   Read More »
December 17, 2012
Teva gains access to Korean market   Read More »
December 14, 2012
Invests in manufacturing infrastructure   Read More »
December 13, 2012
Obtains adequate supply for Phentermine line   Read More »
December 12, 2012
Meets new EU supply chain regulations   Read More »
December 12, 2012
Covers solid dosage, vial-filling activity   Read More »
December 12, 2012
Gains JAK Inhibitor set for Phase III trials   Read More »
December 12, 2012
Strengthens value chain with automation, control buy-in   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On